RRC ID 55686
Author Maruhashi T, Okazaki IM, Sugiura D, Takahashi S, Maeda TK, Shimizu K, Okazaki T.
Title LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII.
Journal Nat Immunol
Abstract The success of tumor immunotherapy targeting the inhibitory co-receptors PD-1 and CTLA-4 has indicated that many other co-receptors might be potential druggable targets, despite limited information about their functional differences. Here we identified a unique target selectivity for the inhibitory co-receptor LAG-3 that was intrinsic to its immunoregulatory roles. Although LAG-3 has been reported to recognize major histocompatibility complex (MHC) class II, it did not recognize MHC class II universally; instead, we found that it selectively recognized stable complexes of peptide and MHC class II (pMHCII). LAG-3 did not directly interfere with interactions between the co-receptor CD4 and MHC class II or between the T cell antigen receptor and MHC class II. Instead, LAG-3 preferentially suppressed T cells responsive to stable pMHCII by transducing inhibitory signals via its intracellular region. Thus, LAG-3 might function more selectively than previously thought and thereby maintain tolerance to dominant autoantigens.
Volume 19(12)
Pages 1415-1426
Published 2018-12-1
DOI 10.1038/s41590-018-0217-9
PII 10.1038/s41590-018-0217-9
PMID 30349037
MeSH Animals Antigens, CD / chemistry Antigens, CD / immunology* CD4-Positive T-Lymphocytes / immunology* Cell Line, Tumor Histocompatibility Antigens Class II / immunology* Humans Lymphocyte Activation / immunology* Lymphocyte Activation Gene 3 Protein Mice Molecular Conformation
IF 23.53
Times Cited 25
Altmetric score
オルトメトリクス指標項目
The most frequently cited source X(Twitter)
Total number of mentions 54
Altmetric score changes over past 6months 0.0
Resource
Human and Animal Cells RAJI(RCB1647)